Pediatric anesthesia & critical care

Anesthetic management of children with medically refractory pulmonary hypertension undergoing surgical Potts shunt

Paediatr AnaesthPublished Retrospective case review

Authors' conclusion

Our single center expereince shows that the Potts shunt surgery, despite high short-term mortaility, may offer another option for palliation in children with medically refractory pulmonary hypertension.

Study context

Population
Children <18 years with medically refractory pulmonary hypertension undergoing surgical Potts shunt, April 2013–June 2022
Participants
29 children
Outcome
Intraoperative management
Methodological detailssingle-centre
  • Single-centre

Main finding

As reported in the abstract

Median age, years (range 4 months to 17.4 years)
12
Placed via thoracotomy
19 (65%)
Placed via median sternotomy with CPB
10 (35%)
Ketamine as induction agent
17 out of 29, 59%
Vasopressin started before intubation
20 out of 29, 69%
Inotropic support before shunt placement: epinephrine
45%
Inotropic support before shunt placement: milrinone
28%
Inotropic support before shunt placement: norepinephrine
17%
Inotropic support before shunt placement: dobutamine
14%
Support after shunt opening: vasopressin
66%
Support after shunt opening: epinephrine
62%
Support after shunt opening: milrinone
59%
Support after shunt opening: dobutamine
14%
Support after shunt opening: norepinephrine
10%

Observational data: associations, not effects.

Safety

Major intraoperative complications and in-hospital mortality

Severe hypoxemia
21 out of 29, 72%
Hypotension requiring epinephrine boluses
10 out of 29, 34.5%
Intraoperative cardiac arrest
0
In-hospital mortalities
4

Original publication

Anesthetic management of children with medically refractory pulmonary hypertension undergoing surgical Potts shunt. Paediatr Anaesth. Published 6 October 2023. doi:10.1111/pan.14764

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.